-
Feb 10, 2026, 11:01 am68 ptsPharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly "deceiving patients and putting their health at risk" by selling compounded versions of its blockbuster GLP-1 medication semaglutide. Novo Nordisk alleges in its lawsuit that Hims & Hers…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.







